POS0306 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS REFRACTORY TO BIOLOGIC THERAPY: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL

D. Van der Heijde; X. Baraliakos; J. Sieper; A. Deodhar; R. Inman; H. Kameda; X. Zeng; Y. Sui; X. Bu; A. Pangan; P. Wung; I. H. Song

doi:10.1136/annrheumdis-2022-eular.2518

Article info

PDF

Scientific Abstracts

Poster Tours

AxSpA: About treatments and outcomes

POS0306 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS REFRACTORY TO BIOLOGIC THERAPY: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL

Free

Authors

D. Van der Heijde Leiden University Medical Center, Rheumatology, Leiden, Netherlands PubMed articles Google scholar articles
X. Baraliakos Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany PubMed articles Google scholar articles
J. Sieper Charité Universitätsmedizin Berlin, Gastroenterology, Infectious Diseases and Rheumatology, Berlin, Germany PubMed articles Google scholar articles
A. Deodhar Oregon Health & Science University, Division of Arthritis & Rheumatic Diseases, Portland, OR, United States of America PubMed articles Google scholar articles
R. Inman Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, and University of Toronto, Immunology, Toronto, Ontario, Canada PubMed articles Google scholar articles
H. Kameda Toho University, Internal Medicine, Tokyo, Japan PubMed articles Google scholar articles
X. Zeng Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Rheumatology and Clinical Immunology, Beijing, China PubMed articles Google scholar articles
Y. Sui AbbVie Inc., Immunology, North Chicago, IL, United States of America PubMed articles Google scholar articles
X. Bu AbbVie Inc., Immunology, North Chicago, IL, United States of America PubMed articles Google scholar articles
A. Pangan AbbVie Inc., Immunology, North Chicago, IL, United States of America PubMed articles Google scholar articles
P. Wung AbbVie Inc., Immunology, North Chicago, IL, United States of America PubMed articles Google scholar articles
I. H. Song AbbVie Inc., Immunology, North Chicago, IL, United States of America PubMed articles Google scholar articles

Citation

Van der Heijde D, Baraliakos X, Sieper J, et al

POS0306 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS REFRACTORY TO BIOLOGIC THERAPY: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL

Annals of the Rheumatic Diseases 2022;81:402-403.

Publication history

First published May 23, 2022.

Online issue publication

June 01, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password